Epicardial device and methods for right heart support during LVAD and cardiac procedures

Abstract

An epicardial implant system prevents right heart failure following left ventricular assist device (LVAD) implantation through dual-mechanism support of the right ventricular free wall and tricuspid valve annulus. The device comprises a biocompatible independent adjustment mechanisms for ventricular wall constraint and annular geometry optimization. The invention simultaneously treats both ventricular dilation and annular valve dysfunction through separate adjustable elements. Epicardial placement eliminates atriotomy requirements while providing real-time hemodynamic optimization. Atraumatic anchoring permits repositioning without tissue damage. Preclinical validation confirms six-minute implantation with independent component efficacy under afterload conditions. The ventricular component prevents dilation while the annular component reduces regurgitation, validating dual-mechanism necessity. The prophylactic approach addresses mechanical disruption causing right heart failure in 40% of LVAD recipients. Applications extend beyond LVAD to coronary bypass, and valvular corrections. Biodegradable embodiments accommodate pediatric cardiac growth. The system provides the first dedicated prophylactic intervention for post-surgical right heart failure across multiple cardiac procedures.

CPC Classifications